Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials*

被引:15
作者
Gengenbach, Laura [1 ]
Reinhardt, Heike [1 ]
Ihorst, Gabriele [2 ]
Ajayi, Stefanie [1 ,3 ]
Dold, Sandra Maria [1 ]
Koehler, Martin [1 ]
Einsele, Hermann [4 ]
Duyster, Justus [1 ,3 ]
Waesch, Ralph [1 ,3 ]
Engelhardt, Monika [1 ,3 ]
机构
[1] Univ Med Ctr Freiburg, Dept Hematol, Oncol, Stem Cell Transplantat, Hugstetterstr 55, D-79106 Freiburg, Germany
[2] Univ Med Ctr Freiburg, Clin Trials Unit, Freiburg, Germany
[3] Univ Med Ctr Freiburg, CCCF, Freiburg, Germany
[4] Julius Maximilians Univ, Med Klin & Poliklin 2, Klinikum Bayr, Wurzburg, Germany
关键词
REAL-WORLD TREATMENT; MANAGEMENT; SURVIVAL; COHORT;
D O I
10.1080/10428194.2018.1448084
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:2692 / 2699
页数:8
相关论文
共 26 条
[1]
[Anonymous], 2016, BLOOD
[2]
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma [J].
Attal, Michel ;
Lauwers-Cances, Valerie ;
Marit, Gerald ;
Caillot, Denis ;
Moreau, Philippe ;
Facon, Thierry ;
Stoppa, Anne Marie ;
Hulin, Cyrille ;
Benboubker, Lofti ;
Garderet, Laurent ;
Decaux, Olivier ;
Leyvraz, Serge ;
Vekemans, Marie-Christiane ;
Voillat, Laurent ;
Michallet, Mauricette ;
Pegourie, Brigitte ;
Dumontet, Charles ;
Roussel, Murielle ;
Leleu, Xavier ;
Mathiot, Claire ;
Payen, Catherine ;
Avet-Loiseau, Herve ;
Harousseau, Jean-Luc .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1782-1791
[3]
A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model [J].
Blommestein, Hedwig M. ;
Verelst, Silvia G. R. ;
de Groot, Saskia ;
Huijgens, Peter C. ;
Sonneveld, Pieter ;
Uyl-de Groot, Carin A. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (02) :198-208
[4]
Engelhardt M, 2016, BLAUE BUCH CHEMOTHER
[5]
Engelhardt M, 2017, DAS BLAUE BUCH
[6]
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients [J].
Engelhardt, Monika ;
Domm, Anne-Saskia ;
Dold, Sandra Maria ;
Ihorst, Gabriele ;
Reinhardt, Heike ;
Zober, Alexander ;
Hieke, Stefanie ;
Baayen, Corine ;
Mueller, Stefan Jurgen ;
Einsele, Hermann ;
Sonneveld, Pieter ;
Landgren, Ola ;
Schumacher, Martin ;
Waesch, Ralph .
HAEMATOLOGICA, 2017, 102 (05) :910-921
[7]
Multidisciplinary Tumor Boards: Facts and Satisfaction Analysis of an Indispensable Comprehensive Cancer Center Instrument [J].
Engelhardt, Monika ;
Selder, Ricarda ;
Pandurevic, Masa ;
Moeller, Mandy ;
Ihorst, Gabriele ;
Waldschmidt, Johannes ;
Herget, Georg ;
Waesch, Ralph .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (09) :E51-E60
[8]
Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores [J].
Engelhardt, Monika ;
Dold, Sandra Maria ;
Ihorst, Gabriele ;
Zober, Alexander ;
Moeller, Mandy ;
Reinhardt, Heike ;
Hieke, Stefanie ;
Schumacher, Martin ;
Waesch, Ralph .
HAEMATOLOGICA, 2016, 101 (09) :1110-1119
[9]
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years [J].
Engelhardt, Monika ;
Ihorst, Gabriele ;
Landgren, Ola ;
Pantic, Milena ;
Reinhardt, Heike ;
Waldschmidt, Johannes ;
May, Annette M. ;
Schumacher, Martin ;
Kleber, Martina ;
Waesch, Ralph .
HAEMATOLOGICA, 2015, 100 (10) :1340-1349
[10]
The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials [J].
Fiala, Mark ;
Dukeman, James ;
Stockerl-Goldstein, Keith ;
Tomasson, Michael ;
Wildes, Tanya ;
Vij, Ravi .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01) :E55-E56